The adjusted VE estimate for the Rotavac vaccine against severe diarrhea using the test-negative design showed a trend toward improvement, which will be important for future rotavirus VE studies to consider.
← all excerpts
Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human-Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India.
1
—
—